Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Is Anticipated To Witness High Growth Owing To Rising Prevalence Of Cancer

Italy Peptide Receptor Radionuclide Therapy (PRRT) Market

The Italy peptide receptor radionuclide therapy (PRRT) market offers significant potential for growth due to the increasing prevalence of various types of cancer in the country. PRRT involves the use of radiolabeled peptides that bind to receptors on cancer cells and deliver radiation therapy internally. The targeted delivery of therapeutic radioisotopes allows for highly effective treatment of neuroendocrine tumors and other cancers. PRRT has emerged as an effective alternative or addition to conventional therapies for metastatic, hormone-resistant, or refractory cancers. Furthermore, PRRT enables non-invasive treatment options with reduced side effects compared to chemotherapy or surgery.


The Global Italy Peptide Receptor Radionuclide Therapy (PRRT) Market is estimated to be valued at US$ 681.79 Mn in 2024 and is expected to exhibit a CAGR of 7.8% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the Italy PRRT market are Beverage Air, Dover Corporation, Hussmann Corporation, Able Products, Precision Refrigeration, Nor-Lake, Infrico, TSSC, Ali Group, UKB, Alto Shaam Inc, Williams Refrigeration, Master-Bilt, Friginox, Adande Refrigeration, Electrolux Professional, American Panel Corporation, Victory Refrigeration, Traulsen, Advanced Equipment Inc. These players are focusing on therapeutics development, expansions, collaborations, and approvals.

There is high potential for market growth due to the rising prevalence of cancer and increasing adoption of PRRT. The Italian regulatory and reimbursement scenario is also quite conducive for the uptake of novel cancer therapeutics like PRRT.

Key players are expanding globally with a focus on Europe and Asia to tap higher growth opportunities. For example, companies are strengthening their presence in countries like Germany, UK, France, China, Japan due to promising demand. Partnerships with regional healthcare providers are also fostering market access.

Market Drivers

Growing Cancer Burden
The rising incidence and prevalence of various types of cancer in Italy are major market drivers. According to estimates, there will be around 377,000 new cancer cases and 149,000 cancer deaths in Italy in 2022. The five most common cancers in Italy are prostate cancer, breast cancer, colon and rectal cancer, lung cancer, and melanoma of the skin.

Increasing Uptake of Targeted Radionuclide Therapies
PRRT has emerged as a promising alternative to chemotherapy, surgery, and external radiation therapy, especially for metastatic neuroendocrine tumors. It offers highly effective treatment while minimizing adverse effects. This is leading to its rising uptake in cancer management in Italy.

Market Restraints
High Treatment Costs
PRRT procedures and required radiopharmaceuticals are costly owing to their specialized nature and production complexities. This poses affordability challenges, limiting widespread adoption.


Segment Analysis
The Italy PRRT Market Scope is dominated by neuroendocrine tumors sub segment currently. Neuroendocrine tumors account for over 65% of the total market share owing to rising incidence rates and need for precision targeting therapies. Peptide receptor radionuclide therapies are highly effective in treating various neuroendocrine tumors by targeting overexpressed somatostatin receptors on tumor cells. Lutathera is the leading commercial PRRT drug approved for treating gastrointestinal and lung neuroendocrine tumors. Rising demand for more efficacious therapy options for hard-to-treat neuroendocrine tumors and approval of Lutathera have driven growth of this sub segment in recent years.

Global Analysis
Regionally, Northern Italy dominates the Italy PRRT market currently. Major cancer centers located in cities like Milan, Turin and Genoa in Northern Italy account for over half of total PRRT procedures conducted in the country. Presence of state-of-the-art nuclear medicine facilities, availability of commercial PRRT drugs like Lutathera and high incidence rates of neuroendocrine tumors have made Northern Italy the fastest growing region. Southern Italy is also emerging as a lucrative market driven by increasing government focus on expanding access to advanced oncology therapies across the country. Rising healthcare investments in Southern regions is likely to strengthen their market position over the coming years.

Get More Insights On Italy Peptide Receptor Radionuclide Therapy (PRRT) Market

Comments

Post a Comment

Popular posts from this blog

Artificial Intelligence is the fastest growing segment fueling the growth of the Da Vinci Systems Market

Image
Da Vinci Systems Market   Da Vinci systems enable surgery through tiny incisions using advanced robotic technologies. They offer surgeons enhanced dexterity, precision and control via a minimally invasive approach, translating to reduced trauma, blood loss and scarring for patients. The global Da Vinci Systems Market is estimated to be valued at US$ 1.76 Bn i n 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends propelling the growth of the Da Vinci Systems Market is the shift towards minimally invasive surgery (MIS). MIS offers major advantages over traditional invasive surgeries such as shorter hospital stays, less pain and scarring, faster recovery times and lower risk of post-operative complications. The enhanced ergonomics and precision of Da Vinci systems renders them highly suitable for complex and delicate MIS procedures. This h
Read more

Smart Bike Computers is fastet growing segment fueling the growth of Cyclocomputer Market

Image
  Cyclocomputer Market  Cyclocomputers are electronic devices that are attached to bicycles to monitor speed, distance, time and other metrics. They help track riding performance and provide navigation. The global Cyclocomputer Market is estimated to be valued at US$ 542.9 Mn or Million in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends in the cyclocomputer market is the emergence of smart bike computers. These computers come with many advanced features like tracking heart rate, power meter readouts, GPS capabilities, onboard maps for navigation and wireless connectivity options to pair with smartphones. They offer more functionality than basic cyclocomputers. Many models now come with touchscreens for easy navigation of menus and stats. Manufacturers are focusing on developing smart bike computers with sleeker designs, longer bat
Read more

Epstein - Barr Virus (EBV) vaccination is fastest growing segment fueling the growth of monovaccine market

Image
Monovaccines  Monovaccines refers to vaccines that provide protection against a single pathogen or disease. EBV monovaccine helps in preventing infectious mononucleosis caused by the Epstein–Barr virus. It offers advantages like conferring lifelong immunity, protection from various cancers associated with EBV infection and reducing disease burden in resource limited countries. The global monovaccine market is estimated to be valued at US$ 10.42 Bn in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the major trends in the monovaccine market is rising investment by manufacturers in research and development of EBV vaccines. As per statistics, around 95% of adult population gets infected by EBV at some point in their life making it an attractive target pathogen for vaccination development. Further, increasing awareness about EBV linked cancers like Bu
Read more